Timing of Dietary Exposure and Breast Cancer Risk

Timing of Dietary Exposure and Breast Cancer Risk - ADVISORS

Lombardi Comprehensive Cancer Center
Department of Oncology
Georgetown University

Dr. Leena Hilakivi-Clarke

U54: The Timing of Dietary Exposure and Breast Cancer Risk

U54 Home Projects Login Investigators Links Publications Microarray Progress

Advisory Committee

The progress of this international study is regularly assessed by an Advisory Broad of leading scientists with expertise in the fields related directly to the research projects. The board members are:

Ritva Butrum, Ph.D.	Olli Kallioneimi, M.D., Ph.D.	Irma Russo, M.D., F.C.A.P.
Richard Pestell, M.B.,B.S., M.D., Ph.D.	Dimitrios Trichopoulos, M.D.	Anna Wu, Ph.D.

Ritva Butrum, Ph.D., Vice President of Research, American Institute for Cancer Research
Dr. Butrum is a nutritionist and Vice President of Research at the American Institute for Cancer Research. AICR is the only peer review funding agency in the United States that supports research only in the area of nutrition and cancer. She has extensive experience in the field of nutritional research and provides her insight regarding all aspects of nutrition related to our program and its individual projects.
Address	American Institute for Cancer Research, 1759 R Street, NW, Washington DC 20009, U.S.A.
Email and Telephone	Email (202) 328-7744

Top of Page

Olli Kallioneimi, M.D., Ph.D. National Human Genome Research Institute
Dr. Kallioniemi is a leader in the field of gene expression and tissues microarrays, participated in the early stages of developing these techniques and has subsequently participated in multiple research projects involving their use. He also participated in initiating in establishing a national consortium in Finland involving families at high risk of developing breast cancer. Dr. Kallioniemi’s role in the advisory board is to provide advice regarding the experiments that involve using gene microarrays (projects I, II and III) and he also will give advise to the members of Statistics and Microarray Core.
Address	Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, 50 South Drive, Building 50, Room 5318, MSC 8000, Bethesda, MD 20892-8000, U.S.A.
Email and Telephone	Email (301) 435-2896

Top of Page

Irma Russo, M.D., F.C.A.P. Chief, Molecular Endocrinology Section, Fox Chase Cancer Center
Dr. Russo is an international leader in the fields of anatomy, pathology and function of the human breast and she and Dr. Jose Russo have characterized in depth the most commonly used animal model of human breast cancer: the DMBA model. She is also a pioneer in studying how timing of hormonal exposures alter mammary gland development. Dr. Russo provides her expertise and advice in all aspects of the the animal research proposed in Projects I, II, and III.
Address	Breast Cancer Research Laboratory, Fox Chase Cancer Center, 701 Burholme Avenue Room C439, Philadelphia, PA, 19111, U.S.A.
Email and Telephone	Email (215) 728-4781

Top of Page

Richard Pestell, M.B.B.S., M.D.,Ph.D. Professor, Albert Einstein Cancer Center
Dr. Pestell is a leader in the field of tumor suppressors and has extensive experience in developing genetically modified animal models. His role in the advisory board is to provide insight for all the experiments using genetically modified mice (projects I, II and III). Dr. Pestell provides advice for the human project that involves studying women at high familial risk for breast cancer (Project V).
Address	Department of Developmental and Molecular Biology, The Albert Einstein Cancer Center, Chanin Building, Room 302A,Bronx, New York, NY 10461
Email and Telephone	Email (718) 430-8662

Top of Page

Dimitrios Trichopoulos, M.D. Professor, Harvard School of Public Health
Dr. Trichopoulos was the first to propose the hypothesis that the in utero environment may play an important role in affecting breast cancer risk. He also pioneered the first studies that showed the ability of the estrogenicity of pregnancy to affect a mother’s risk of developing breast cancer. Several investigators around the world have subsequently proven the validity of his hypotheses. Dr. Trichopoulos will provide advice for the entire research program, with particular focus on the studies proposed in project V.
Address	Department of Epidemiology, Harvard School of Public Health, Kresge Building, 9th Floor, 677 Huntington Avenue, Boston, MA 02115, U.S.A.
Email and Telephone	Email : (617) 432-4560

Top of Page

Anna Wu, Ph.D. Professor, University of Southern California
Dr. Wu is a leader in epidemiological research into the role of soy intake and breast cancer risk and the key investigator in several international studies into whether soy consumption affects the risk of developing cancers or other diseases. She will give insight for the animal studies in Projects I and III that investigate the timing of genistein exposure and breast cancer risk. Dr. Wu will also provide overall advice relating to assessing dietary intakes in projects IV and V.
Address	Preventive Medicine Division, Keck School of Medicine, Building: NOR4443 MailCode:9175, University of Southern California,Los Angeles, CA 90089-9034
Email and Telephone	Email (323) 865-0484

Top of Page


U54 Home	Projects	Login	Investigators	Links	Publications